Home > News > Whipsawed Nanotech VC Value
June 26th, 2007
Whipsawed Nanotech VC Value
It's no secret that certain nanotechnology stocks get whipsawed as news and investor enthusiasm for this new science heats up and then cools. Publicly traded nanotechnology venture capital firm Harris & Harris Group (nasdaq: TINY - news - people ) is a case in point.
This New York City-based firm is invested in a diversified range of early-stage nanotech companies. Its portfolio consists of 27 private companies, and its shares trade mostly on investor hype over their potential for growth. Earlier this month, the stock hovered around $11.50, with a market cap of $245.2 million. But with net assets of $113,930,303 and 21,015,017 shares outstanding at the end of 2006, TINY's net asset value (NAV) per outstanding share was $5.42. That means investors were getting $5.42 worth of value for a share price of $11.50--not a great trade if you're measuring performance by the usual metrics of sales and profits.
But, as I've written in earlier issues, conventional valuation metrics do not apply well to business development companies (BDCs) like Harris & Harris or similar firms, such as Allied Capital (nyse: ALD - news - people ) or MCG Capital (nasdaq: MCGC - news - people ). Since the growth of BDCs is so closely linked to the potential appreciation of their portfolios, most investors pay closer attention to the NAV--or more specifically, to how the share price compares with the NAV. Even by that measure, however, TINY's stock would seem overvalued.
Harris & Harris Group Reports Financial Statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015
Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Nanomedicine shines light on combined force of nanomedicine and regenerative medicine March 31st, 2015
Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015
Super sensitive measurement of magnetic fields March 31st, 2015
From tobacco to cyberwood March 31st, 2015